$LLY #LLY
LLY Latest Market Analysis — Oct. 8, 2026
Eli Lilly and Company (NYSE: LLY) is showing short-term weakness after yesterday’s 2.7% gain. The latest available quote is around $1,137, with the stock testing the $1,130–$1,115 support zone. �
StockAnalysis.com +1
Key levels
🟢 Support: $1,130–$1,115
🔴 Resistance: $1,190–$1,210
🎯 Upside targets: $1,250–$1,290
⚠️ Risk level: Below $1,110
📅 Next earnings: Oct. 29, 2026 �
Eli Lilly Investors
Bias: Bullish only if support holds and price reclaims $1,190 with strong volume. A break below $1,110 would weaken the setup.
#MarketAnalysis" #IMFSaysTokenizedMarketsSmall #FedMinutesFocusOnOctoberPause
LLY Latest Market Analysis — Oct. 8, 2026
Eli Lilly and Company (NYSE: LLY) is showing short-term weakness after yesterday’s 2.7% gain. The latest available quote is around $1,137, with the stock testing the $1,130–$1,115 support zone. �
StockAnalysis.com +1
Key levels
🟢 Support: $1,130–$1,115
🔴 Resistance: $1,190–$1,210
🎯 Upside targets: $1,250–$1,290
⚠️ Risk level: Below $1,110
📅 Next earnings: Oct. 29, 2026 �
Eli Lilly Investors
Bias: Bullish only if support holds and price reclaims $1,190 with strong volume. A break below $1,110 would weaken the setup.
#MarketAnalysis" #IMFSaysTokenizedMarketsSmall #FedMinutesFocusOnOctoberPause